Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
MRK
NVS
Add up to 3 more stocks
MRK
Merck & Co., Inc.
+0.34%
$144.30+0.49Delayed quote: Oct 2, 2026, 4:02 PM EDT
Market Cap
$356.40B
52W Range
$82.01 - $156.92
NVS
Novartis AG
-0.04%
$141.00-0.05Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$268.00B
52W Range
$121.57 - $170.46
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 115.44 | 21.27 |
| Forward P/E | 52.76 | 16.02 |
| PEG Ratio | 5.44 | 1.38 |
| P/B Ratio | 8.50 | 6.45 |
| P/S Ratio | 5.37 | 4.82 |
| P/FCF Ratio | 22.19 | 16.94 |
| EV/EBITDA | 22.81 | 13.85 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 75.4% | 74.4% |
| Operating Margin | 36.2% | 30.5% |
| Net Margin | 4.8% | 22.9% |
| ROE | 7.6% | 30.7% |
| ROA | 2.4% | 10.5% |
| ROIC | 5.8% | 13.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.32 | 0.86 |
| Quick Ratio | 1.10 | 0.67 |
| Debt/Equity | 1.29 | 1.18 |
| Interest Coverage | 17.31 | 14.38 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.4% | 3.4% |
| Payout Ratio | 272.0% | 71.5% |
| Yrs of Dividend Growth | 15 | 1 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.